NPPB and hydrops fetalis: Along with the novelty represented by specific NT-proBNP cut-points, it is noteworthy that dosing NT-proBNP in stable asymptomatic outpatients with CV comorbidities represents not only a mere HF risk evaluation but strongly impacts management strategies.